Delaware Health Officials Issue Warning after 2 Deaths Involve Same Stamp on Packets of Heroin

Secretary Kara Odom Walker participates in a press conference about the opioid epidemic in Delaware.

NEW CASTLE (May 28, 2018) – Department of Health and Social Services (DHSS) Secretary Dr. Kara Odom Walker is warning people in active substance use in Delaware that two people have died from suspected overdoses in a 24-hour period that involve heroin packets with the same stamp. DHSS is not identifying the stamp so people will not seek out the drug.

“If you are in active use, we urge you to seek treatment immediately,” Secretary Walker said. “Call DHSS’ 24/7 Crisis Hotline or seek help at the nearest police department, hospital or medical provider. If you continue to use substances, have the overdose-reversing medication naloxone with you because the risk for death is increased. Our first priority is to reduce harm and to save your life or the lives of others.”

By calling DHSS’ 24/7 Crisis Services Hotline, individuals in active use or their loved ones will be connected to trained crisis professionals who can discuss treatment options. In Kent and Sussex counties, the number is 1-800-345-6785. In New Castle County, the number is 1-800-652-2929. Individuals and families also can visit DHSS’ website, www.HelpIsHereDE.com, to find addiction treatment and recovery services in Delaware or nearby states.

In Delaware, there have been 106 deaths from suspected overdoses through May 27 of this year, including three since Friday, May 25, according to preliminary reports from the Department of Safety and Homeland Security’s Division of Forensic Science. The two deaths involving the same stamp occurred Thursday, May 24, and Friday, May 25. Of the 106 total deaths for 2018, 71 have been in New Castle County, 22 in Sussex County and 13 in Kent County, The youngest person who died was 19; the oldest 74.

Elizabeth Romero, director of DHSS’ Division of Substance Abuse and Mental Health, encouraged individuals in Delaware to call 911 if they believe someone is overdosing. Under Delaware’s 911/Good Samaritan Law, people who call 911 to report an overdose and the person in medical distress cannot be arrested for low-level drug crimes.

“When someone overdoses from an opioid, naloxone must be administered within minutes,” Romero said. “That’s why it’s so important for people to call 911 immediately. We also urge people to have naloxone on hand if they have a loved one suffering from addiction. Naloxone saves lives.”

If a user has ingested fentanyl or a drug laced with fentanyl, time is critical because the powerful opioid quickly affects the central nervous system and the brain. Users often have trouble breathing or can stop breathing as the drug sedates them. If someone is too drowsy to answer questions, is having difficulty breathing, or appears to be so asleep they cannot be awakened, call 911 immediately and administer naloxone if you have the medication.

Naloxone, the overdose-reversing medication carried in Delaware by community members, paramedics and some police officers, can be administered in overdoses involving fentanyl. Because fentanyl is more potent than heroin or opioid painkillers, multiple doses of naloxone may be needed to reverse an overdose. In 2017, Delaware paramedics and police officers administered naloxone 2,714 times in suspected overdose situations to a total of 1,906 patients.

Overdose deaths continue to increase in Delaware. In 2017, 345 people died from overdoses, up 12 percent from the 308 people who died in 2016, according to the Division of Forensic Science. Of the 345 overdose deaths last year, 210 – or about six out of 10 – involved fentanyl. That number was almost double the 109 fentanyl-related deaths in 2016.

 


Delaware Files Lawsuit Against Opioid Industry

Suit Seeks To Hold Manufacturers, Distributors and Retailers Responsible for Cost, Impact of Prescription Opioid Epidemic

On behalf of Delawareans, Attorney General Matt Denn filed suit Friday against some of the nation’s largest manufacturers, distributors, and retailers of prescription opioid drugs, alleging that their failures to meet their legal obligations have fueled an opioid addiction epidemic that is devastating individuals, families, and communities across Delaware.

The lawsuit seeks to hold them financially responsible for the harm they have caused to the State and its citizens and to require them to change their conduct to help end the epidemic.

“Opioid manufacturers misrepresented the addictive nature of their products. They, along with national opioid distributors and national pharmacies, knew that they were shipping quantities of opioids around the country so enormous that they could not possibly all be for legitimate medical purposes, but they failed to take basic steps to ensure that those drugs were going only to legitimate patients,” Attorney General Denn said. “These companies ignored red flags that opioids were being diverted from legitimate channels of distribution and use to illicit channels. The failure of these corporate defendants to meet their legal obligations has had a devastating impact on Delawareans.”

Delaware’s lawsuit cites statistics showing that, each year, more than 50 opioid pills are shipped into Delaware for every man, woman, and child in the state. When limited to persons – including those who received prescriptions for a week or less following minor medical procedures – who actually have used opioids, the estimated number is 440 pills per person per year.

The manufacturer defendants named in Delaware’s lawsuit are Purdue Pharma and Endo Pharmaceuticals. The distributor defendants named in the lawsuit are McKesson, Cardinal Health, Amerisource Bergen, Anda Pharmaceuticals, and H.D. Smith. The retailer defendants named in the lawsuit are CVS and Walgreens. Other defendants may be named in the future.

“The filing of this suit is an important step in what will likely be complex and time-intensive litigation against sophisticated national corporations,” Attorney General Denn said. “But these defendants must be held accountable for the damage that they have caused to our state and its citizens.”

The lawsuit, filed in Delaware Superior Court’s Complex Commercial Litigation Division, can be found here.


Governor Carney Signs Package of Legislation to Combat Addiction Crisis

New laws expand access to substance abuse treatment, remove insurance barriers, and strengthen oversight of prescriptions

WILMINGTON, Del. – Governor John Carney on Tuesday signed into law Senate Bill 41, House Bill 91, and House Bill 100, a bipartisan package of legislation that will expand access to substance abuse treatment, strengthen oversight of opioid prescriptions, and combat Delaware’s addiction crisis.

Governor Carney signed the legislation during a ceremony that included remarks from Attorney General Matt Denn, members of the General Assembly, and Delaware advocates for improved access to substance abuse treatment – including families who have lost loved ones to Delaware’s opioid epidemic.

May 30 Bill Signings

“Far too many Delawareans, and Delaware families, have been affected by this crisis,” said Governor Carney. “These new laws represent a significant step forward in our efforts to combat Delaware’s addiction epidemic. To the Delaware families who have lost loved ones to addiction, and who are now fighting to prevent others from experiencing the same fate, your work is nothing short of inspiring. To the Delawareans who are using your own experience with substance abuse to help others, know that you are making a difference. We will continue to follow your lead. Thank you to Attorney General Denn and members of the General Assembly for your continued urgency on this issue.”

“The credit for these bills should go to the Delawareans who have overcome substance abuse, and the families who lost loved ones to drug overdoses, who stepped forward and shared their thoughts about where the system was failing and how it could be improved,” said Attorney General Matt Denn. “We listened and tried to turn their suggestions into laws, but the ideas came from those families, and after giving us the ideas they stood shoulder to shoulder with us to make sure the bills were passed.”

“I truly feel that every life matters,” said MaryBeth Cichocki, who lost her son to opioid addiction, and advocated for the new laws. “We are all one injury or surgery away from the disease that continues to take the lives of those we love. As long as I breathe, Matt will continue to live.”

“We are grGov. Carney signs legislation.ateful for all those responsible for the passing of these bills,” said Don Keister, a founder of atTAcK Addiction, whose son lost his battle with addiction. “When families need help, it’s important that services are available without additional delays. If these laws had been around when our son was battling this disease, he may still be alive today.”

Legislation signed into law on Tuesday will take a number of steps to expand access to substance abuse treatment, target barriers to insurance coverage, and improve Delaware’s response to the addiction epidemic.

The package will:

• Prevent private insurers from using pre-authorization and referral requirements to delay access to substance abuse treatment;
• Require insurance companies to cover 14 days of substance abuse treatment before conducting a “utilization review” that can delay treatment;
• Limit insurance companies from denying substance abuse treatment based on “medical necessity” grounds;
• Allow the Department of Justice to use consumer protection funds to advocate for those being denied coverage based on “medical necessity” grounds;
• Establish a new committee to help oversee opioid prescriptions, and strengthen the oversight of over-prescription.

“Even with limitless support, battling addiction is incredibly difficult. But it shouldn’t be made harder by insurance companies and health care providers standing in the way of critical treatment,” said Senate Majority Leader Margaret Rose Henry, the lead Senate sponsor of House Bill 100. “I am grateful to Governor Carney for signing this important legislation into law, so Delawareans never again have to worry about whether they’re covered by insurance before seeking substance abuse treatment that could save their lives.”

“Delawareans who take the initiative to seek treatment for substance abuse shouldn’t have to wade through red tape to get the help they need,” said Senator Stephanie Hansen, the prime sponsor of Senate Bill 41. “I appreciate the Attorney General’s leadership in helping us pass this important legislation, which ensures that insurance companies are forbidden from imposing pre-certifications, screenings, prior authorizations or referrals for those ready to make the potentially life-saving decision to get help.”

“In light of the scourge of addiction, we need to get these people appropriate treatment, when it’s needed,” said Senator Dave Lawson. “Current coverages are insufficient.”

“These measures are necessary first steps towards addressing the needs of a significant portion of the more than 90,000 Delawareans currently suffering from addiction. We mustn’t fail to provide safety-nets for those in need of immediate treatment, and we must work to ensure current policies align with the increasing needs of Delawareans affected by addiction,” said Senator Anthony Delcollo. “Lastly, we cannot continue to operate in a vacuum when addressing addiction, and I am committed to working with my colleagues to aggressively pursue solutions to improve the lives of almost 100,000 Delawareans affected by this horrific disease.”

“If people struggle and stumble as they seek treatment, they should have the ability to come back and get treated again. Addiction is a disease, just like cancer and diabetes, and should be considered as one when it comes to medical treatment. Delawareans struggling with addiction should be extended a helping hand when they seek treatment, not have the door shut in their faces,” said Representative Helene Keeley, the prime Bill Signingssponsor of House Bill 100. “These combined efforts provide us with the necessary resources to battle the opioid epidemic in the First State and remove the stigma associated with substance abuse.”

“These bills will help save lives in Delaware and I am proud to be part of this effort to combat the disease of addiction. Substance abuse treatment helps people reintegrate into society and lead productive lives,” said Representative Michael Mulrooney, the prime sponsor of House Bill 91. “If we deny people suffering from substance abuse the treatment they need, it can lead them to relapse and either end up in the criminal justice system or worse.”

“This package of legislation represents best practices that we are implementing in Delaware in order to strategically address our concerns in battling the heroin and opioid epidemic,” said Representative Ruth Briggs King. “And, we are not done yet. Other bills, such as the substance-exposed infant legislation is working its way through Legislative Hall and should be our next primary focus in this ongoing effort to combat this epidemic.”

“These bills are key to fighting the opioid epidemic in Delaware because they address a very important component of this process – making sure adequate treatment is available to those who need it,” said Representative Tim Dukes. “Without access to treatment, all our efforts may as well be considered for nothing.”

“Collectively, these bills also add to the public awareness that addiction is a disease, that it can be treated, and people do recover,” said Dr. Kara Odom Walker, Secretary of the Department of Health and Social Services. “With addiction, we know that when people are ready for treatment, the window can be small in terms of connecting them to that critical care. At the Department of Health and Social Services, we will do everything in our power to connect that person to the treatment they seek.”

###

Related news:
Delaware to Participate in NGA’s Bipartisan Health Reform Learning Network
DHSS Relaunches ‘Help is Here’ Website with Accompanying Prevention, Treatment, and Recovery Support Campaign


Governor Carney Will Sign Package of Legislation to Combat Addiction Crisis

Legislation expands access to substance abuse treatment, and strengthens oversight of prescriptions

WILMINGTON, Del. – Governor John Carney on Tuesday will sign into law Senate Bill 41, House Bill 91, and House Bill 100, a package of legislation that will expand access to substance abuse treatment, strengthen oversight of opiate prescription patterns and combat Delaware’s addiction crisis.

WHEN:     2 p.m., Tuesday, May 30

WHERE:  Governor’s Office, Carvel State Office Building, 12th Floor
820 N. French Street, Wilmington

WHO:     Governor John Carney
Lieutenant Governor Bethany Hall-Long
Attorney General Matt Denn
Senator Stephanie Hansen
Senator Margaret Rose Henry
Senator Anthony Delcollo
Representative Helene Keeley
Representative Michael Mulrooney
Dr. Kara Odom Walker, Secretary, Department of Health and Social Services
MaryBeth Cichocki
Dave Humes, atTAcK Addiction
Gail Humes, atTAcK Addiction
Don Keister, atTAcK Addiction
Jeanne Keister, atTAcK Addiction
Additional advocates